+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Heart disease covers a range of conditions that affect how the heart works, including blocked arteries, abnormal rhythms, and changes in heart muscle. It often develops as people get older or when risk factors like high blood pressure, diabetes, or s...

Search Bar & Filters

Found 589 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are investigating heart damage caused by certain cancer treatments, such as anthracycline chemotherapy and HER2-targeted therapy, which can affect the hearts function. The study aims to compare a newer heart ultrasound technique called three-dimensional speckle-tracking echocardiography 3D strain with the standard two-dimensional 2D method to see if it detects early heart damage better. This research focuses on adults with breast cancer, lymphoma, or sarcoma undergoing these cancer treatments at Skne University Hospital in Sweden. Participants receive heart ultrasounds, ECGs, and blood tests for heart-related biomarkers before, during, and after their cancer treatment. Those with breast cancer typically have heart imaging every 3 to 4 months, while those with lymphoma or sarcoma have imaging at baseline, 6 months, and 24 months after starting treatment. Blood samples are also collected and stored for future research. Some participants showing signs of heart damage, along with matched controls, may be invited for detailed heart MRI scans. Throughout the study, researchers track changes in heart function using both 3D and 2D ultrasound measures, along with blood biomarkers. They record heart failure medication starts, hospitalizations, and overall survival from health records. This observational study does not alter clinical care, and the imaging results from 3D strain are analyzed separately. Participation involves regular heart assessments over up to 24 months depending on the cancer type.

Age: 18Years +All Genders
1 location
C

Actively Recruiting

Healthy Volunteer

The trial compares the time taken to record a complete Electrocardiogram ECG using a novel 4-electrode tablet device called DigitalCardio CardioSecur4 with a standard 12-lead ECG device in adults with cardiac conditions. It aims to determine differences in recording time, trace quality, and healthcare professional satisfaction between the two ECG methods. The study uses a randomized, crossover design with hospitalized and outpatient cardiology patients who are hemodynamically stable and able to consent. Participants are randomly assigned to one of two groups Group A undergoes the standard 10-electrode ECG first followed immediately by the 4-electrode DigitalCardio ECG, while Group B receives the DigitalCardio ECG first followed by the standard ECG. Both ECG recordings are performed by the same operator within a short interval to ensure consistency. Anonymized ECG traces are assessed independently for quality, diagnostic parameters, and any missing or erroneous leads. During the trial, researchers measure the total time from electrode placement to complete ECG trace capture for each device. Healthcare professionals complete a questionnaire to evaluate their satisfaction with the DigitalCardio system. The study includes initial screening for eligibility and informed consent. Outcome measures include procedure time comparison, trace quality, diagnostic concordance, user satisfaction, and technical incident rates. The trial is conducted in a single day per participant with no long-term follow-up.

Age: 18Years +All GendersPhase Not Applicable
2 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating new cardiovascular magnetic resonance CMR imaging techniques to improve current CMR protocols for diagnosing various cardiac diseases. The study aims to create a standardized 10-minute CMR protocol that focuses on heart function and tissue characterization without using contrast injections. This protocol is intended to be applicable for about 70% of cardiac patients, including those with non-ischemic cardiomyopathies, ischemic heart disease, and coronary artery disease. The study compares the new 10-minute SMART CMR protocol with the standard CMR exams to assess its diagnostic accuracy, clinical usefulness, and cost-effectiveness. Participants include healthy volunteers without significant cardiovascular or respiratory conditions and patients who require clinically indicated CMR exams. The study evaluates the ability of the SMART CMR to improve diagnostic decisions and reduce costs compared to existing methods. Participants undergo CMR imaging sessions where researchers collect various measurements such as myocardial tissue characteristics, heart function, and blood flow. The study monitors completion rates of the scans, records any adverse events, and compares scan times and costs between the new and standard protocols. Data on reproducibility and variability of imaging results are also collected. The trial runs through 2027, with ongoing assessments and follow-up to evaluate the effectiveness and feasibility of the new CMR approach.

Age: 18Years +All Genders
1 location
S

Actively Recruiting

Researchers are studying recovery after heart surgery for people with Complex Congenital Heart Disease CCHD to understand the main risk factors affecting recovery. The study also aims to build a comprehensive data platform to support CCHD care throughout a persons life and develop a China-specific quality control system to improve surgical outcomes and guide national health policies. The study includes two groups a retrospective group of 2,494 patients who already had CCHD surgery and are in an existing national database, and a prospective group of 1,940 patients scheduled for surgery as part of related sub-studies. Data collected include pre-surgery tests, surgical details, care during and after surgery, and follow-up for up to one year. Researchers will combine data from both groups to build a new registry and quality control system. Participants will have their medical records analyzed or have data collected during their care, depending on their group. Researchers will monitor recovery and outcomes up to one year after surgery, using the combined data to identify risk factors and develop a surgical quality control system. The study spans up to 48 months, aiming to improve CCHD care across all ages in China.

All AgesAll Genders
1 location
S

Actively Recruiting

This research aims to understand how abnormal lipid metabolism, which is common after organ transplantation, relates to transplant rejection and failure. It focuses on cardiac transplant patients who often experience lipid changes due to immunotherapy. The study explores the interaction between PCSK9, lipid disorders, and immune responses, which may contribute to transplant rejection. The goal is to clarify these links to improve management of lipids during and after surgery. The study involves tracking heart transplant patients over a long term to observe lipid changes and their connection to rejection. It expands testing beyond traditional lipid assays to include transcriptomic, proteomic, and metabolomic analyses to better understand PCSK9s role in dyslipidemia. Single-cell sequencing is used to investigate how these lipid changes affect T-cell-mediated rejection of the transplanted heart. Participants will be followed for four years, during which blood lipid levels and graftpatient survival will be monitored. Additional assessments include measuring heart function through left ventricular ejection fraction at rest. This observational study collects detailed biological data and monitors health outcomes to deepen understanding of how lipid metabolism influences transplant success and patient survival.

Age: 18Years +All Genders
1 location
E

Actively Recruiting

Researchers are evaluating the accuracy of myocardial imaging using integrated 18F-FDG PETMR to detect viable heart muscle in patients with ischemic heart disease. The study also aims to see if this imaging method can replace the current standard that combines 18F-FDG PET with 99mTc MIBI SPECTCT gated myocardial perfusion imaging. This is important as assessing heart muscle viability helps predict treatment success and select the best surgical options, especially before coronary artery bypass grafting CABG. Participants will undergo two procedures within two weeks before surgery an integrated 18F-FDG PETMR scan, and a combined 18F-FDG PETMR plus 99mTc MIBI gated myocardial perfusion imaging. These imaging techniques allow doctors to evaluate heart blood flow, metabolism, muscle vitality, and function simultaneously. The study focuses on patients with significant coronary artery narrowing and reduced heart function, some of whom may also receive stem cell treatments alongside CABG. During the study, participants will sign informed consent and complete the imaging scans, with outcome measures including myocardial perfusion and metabolic imaging assessed approximately two days after the scans. Researchers will monitor heart function and muscle viability to help determine surgical outcomes. The study runs until 2026 and involves adults under 80 years with specific heart conditions, ensuring comprehensive assessments to support future heart disease treatments.

Age: 0 - 80YearsAll Genders
1 location
C

Actively Recruiting

Researchers are evaluating the use of Near Infrared Spectroscopy NIRS to predict acute kidney injury AKI in adult patients undergoing cardiac surgery with cardiopulmonary bypass. AKI is a common and serious complication after such surgeries, leading to increased hospital stays, costs, and mortality. This study aims to compare the effectiveness of NIRS sensors placed on the skin over the kidney versus sensors placed on the limbs for predicting AKI. The research is conducted by the University of Utahs anesthesiology department. Participants will have NIRS sensors placed on the skin over their kidney, as located by ultrasound, and on the muscles of their arm and thigh before surgery. If a patient has had a right nephrectomy, the sensor will be placed over the left kidney. Additional sensors will be placed on the forehead to measure brain oxygen levels during surgery. The study observes how well these sensor placements predict AKI from the day of surgery up to seven days afterward. During the study, participants will undergo ultrasound measurements to determine the depth of kidney and muscle tissue before sensor placement. Researchers will monitor oxygen levels in various tissues throughout surgery and track outcomes such as AKI development, ventilator times, length of hospital stay, and in-hospital mortality up to three months. Hemodynamic data including blood pressure, oxygen delivery, vasopressor use, and anemia during surgery will also be recorded. The total observation period extends from surgery through hospital discharge and follow-up for up to three months.

Age: 18Years +All Genders
1 location
A

Actively Recruiting

Healthy Volunteer

Researchers are conducting an observational study to gather information on the prevalence, treatment, and outcomes of congenital heart disease CHD throughout patients lives in China. The study focuses on various stages, from fetal diagnosis to early treatment of severe CHD in newborns, and includes standardized care for pregnant patients with CHD. The aim is to improve diagnosis and treatment at participating hospitals, especially for complex cases, and to promote uniform clinical practices in cardiovascular care across China, ultimately enhancing medical service quality and informing national treatment guidelines. The study will be carried out by Beijing Anzhen Hospital and the National Clinical Research Center for Cardiovascular Diseases, involving over 20 hospitals over five years. Starting January 1, 2024, each hospital will collect data on CHD inpatient cases monthly. A dedicated website will support data collection, education, training, and experience sharing. The project includes regular analysis and reporting of quality indicators, with guidance and support provided to hospitals to address issues and improve care. Hospitals showing excellence and improvement will be recognized to encourage overall quality advancement. Participants will be patients diagnosed with various forms of congenital heart disease. The study will monitor outcomes including mortality within the first week after surgery, rates of integrated prenatal and postnatal diagnosis and treatment, surgical intervention rates in newborns, and medium- to long-term survival and reoperation rates up to five years after discharge. Data collection will continue monthly, with ongoing education and quality improvement efforts, and the study is expected to last until January 1, 2030.

All AgesAll Genders
1 location
R

Actively Recruiting

Healthy Volunteer

Researchers are observing patients at preventive cardiology clinics to better understand how cardiovascular risk assessment tools can be used most effectively. The study aims to explore how these tools influence the risk of cardiovascular disease CVD and related outcomes, focusing on both primary and secondary prevention. This ongoing research collects data to help clinicians develop personalized, effective treatment plans by combining individual risk factors. The study involves adult patients attending the National Institute of Cardiovascular Diseases NICVD in Karachi, Pakistan. It gathers detailed information such as demographic data, physical exams, clinical history, risk modifications, laboratory tests, and risk scores like the ASCVD and WHO Cardiovascular Risk scores. These assessments are recorded at the first visit and during follow-ups to track changes over time. Participants provide verbal consent and are followed over a long period, with data collection continuing regularly. Researchers analyze this information to measure cardiovascular risk over ten years, changes in risk levels, and cardiovascular-related deaths. The study uses structured questionnaires and statistical methods to evaluate the findings, aiming to contribute valuable insights into cardiovascular disease prevention and management.

Age: 18Years - 90YearsAll Genders
1 location
S

Actively Recruiting

Researchers are evaluating a predictive tool called the Multifactorial Dynamic Perfusion Index MDPI to estimate the risk of acute kidney injury after cardiac surgery involving cardiopulmonary bypass CPB. This observational study involves adults and infants undergoing cardiac surgery, aiming to validate the MDPI in adults, develop a version for infants under 20 kg, and explore if the MDPI can predict other complications including mortality. The MDPI combines seven variables measured during CPB, many of which can be modified by the surgical team to potentially improve patient outcomes. The study is divided into three parts first, validating the MDPI in 800 adult cardiac surgery patients from two centers using existing CPB monitors that collect data such as hematocrit, oxygen delivery, arterial pressure, and transfusions second, developing a modified MDPI for 200 infants under 20 kg undergoing congenital heart surgery with additional infant-specific variables and third, investigating whether the MDPI can predict other postoperative issues like low cardiac output, longer ICU stays, bleeding complications, and 30-day mortality. Data collection includes parameters recorded during surgery and postoperative creatinine values. Participants will undergo cardiac surgery with CPB, during which relevant physiological data will be continuously recorded by specialized monitors. After surgery, kidney function and other outcomes will be monitored for up to 48 hours, with extended follow-up for complications and mortality over 30 days. Researchers will analyze how well the MDPI predicts acute kidney injury and other clinical outcomes, aiming to incorporate the MDPI into real-time monitoring devices to guide therapeutic decisions during surgery.

Age: 18Years +All Genders
1 location

1-10 of 589

1

Frequently Asked Questions